Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
ECBK vs NBTB vs CARE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
ECBK vs NBTB vs CARE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $178M | $2.44B | $686M |
| Revenue (TTM) | $80M | $902M | $252M |
| Net Income (TTM) | $8M | $169M | $31M |
| Gross Margin | 39.9% | 73.6% | 61.2% |
| Operating Margin | 13.1% | 24.3% | 15.9% |
| Forward P/E | 21.6x | 11.2x | 5.7x |
| Total Debt | $285M | $327M | $179M |
| Cash & Equiv. | $95M | $185M | $105M |
ECBK vs NBTB vs CARE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | Jun 26 | Return |
|---|---|---|---|
| ECB Bancorp, Inc. (ECBK) | 100 | 145.3 | +45.3% |
| NBT Bancorp Inc. (NBTB) | 100 | 115.1 | +15.1% |
| Carter Bankshares, … (CARE) | 100 | 221.9 | +121.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ECBK vs NBTB vs CARE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ECBK carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 16.5%, EPS growth 95.8%
- Lower volatility, beta 0.44, current ratio 0.10x
- PEG 1.16 vs NBTB's 1.59
NBTB is the clearest fit if your priority is income & stability and bank quality.
- Dividend streak 13 yrs, beta 0.73, yield 3.1%
- NIM 3.1% vs ECBK's 2.0%
- 3.1% yield; 13-year raise streak; the other 2 pay no meaningful dividend
CARE is the clearest fit if your priority is long-term compounding.
- 150.2% 10Y total return vs NBTB's 103.1%
- +86.8% vs NBTB's +20.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.5% NII/revenue growth vs CARE's 6.2% | |
| Value | PEG 1.16 vs 1.59 | |
| Quality / Margins | Efficiency ratio 0.3% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.44 vs NBTB's 0.73 | |
| Dividends | 3.1% yield; 13-year raise streak; the other 2 pay no meaningful dividend | |
| Momentum (1Y) | +86.8% vs NBTB's +20.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NBTB's 0.5% |
ECBK vs NBTB vs CARE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ECBK vs NBTB vs CARE — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 3 of 6 categories
CARE leads 1 • ECBK leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $902M annually — 11.3x ECBK's $80M. NBTB is the more profitable business, keeping 18.8% of every revenue dollar as net income compared to ECBK's 9.8%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $80M | $902M | $252M |
| EBITDAEarnings before interest/tax | $11M | $241M | $46M |
| Net IncomeAfter-tax profit | $8M | $169M | $31M |
| Free Cash FlowCash after capex | $9M | $225M | $30M |
| Gross MarginGross profit ÷ Revenue | +39.9% | +73.6% | +61.2% |
| Operating MarginEBIT ÷ Revenue | +13.1% | +24.3% | +15.9% |
| Net MarginNet income ÷ Revenue | +9.8% | +18.8% | +12.5% |
| FCF MarginFCF ÷ Revenue | +11.3% | +24.9% | +11.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +82.4% | +39.5% | +8.3% |
Valuation Metrics
Evenly matched — ECBK and NBTB each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 14.0x trailing earnings, NBTB trades at a 37% valuation discount to CARE's 22.1x P/E. Adjusting for growth (PEG ratio), ECBK offers better value at 1.16x vs NBTB's 1.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $178M | $2.4B | $686M |
| Enterprise ValueMkt cap + debt − cash | $368M | $2.6B | $759M |
| Trailing P/EPrice ÷ TTM EPS | 21.61x | 14.02x | 22.11x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.18x | 5.67x |
| PEG RatioP/E ÷ EPS growth rate | 1.16x | 1.99x | — |
| EV / EBITDAEnterprise value multiple | 35.47x | 10.70x | 18.98x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 2.81x | 2.69x |
| Price / BookPrice ÷ Book value/share | 0.98x | 1.25x | 1.66x |
| Price / FCFMarket cap ÷ FCF | 19.80x | 11.13x | 21.57x |
Profitability & Efficiency
NBTB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $5 for ECBK. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECBK's 1.66x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs NBTB's 7/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +9.5% | +7.6% |
| ROA (TTM)Return on assets | +0.5% | +1.1% | +0.7% |
| ROICReturn on invested capital | +1.8% | +7.9% | +5.7% |
| ROCEReturn on capital employed | +2.3% | +2.4% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 8 |
| Debt / EquityFinancial leverage | 1.66x | 0.17x | 0.43x |
| Net DebtTotal debt minus cash | $190M | $142M | $73M |
| Cash & Equiv.Liquid assets | $95M | $185M | $105M |
| Total DebtShort + long-term debt | $285M | $327M | $179M |
| Interest CoverageEBIT ÷ Interest expense | 0.22x | 1.05x | 0.39x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $23,985 today (with dividends reinvested), compared to $14,414 for ECBK. Over the past 12 months, CARE leads with a +86.8% total return vs NBTB's +20.5%. The 3-year compound annual growth rate (CAGR) favors CARE at 26.8% vs NBTB's 14.5% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +17.3% | +14.0% | +59.9% |
| 1-Year ReturnPast 12 months | +34.3% | +20.5% | +86.8% |
| 3-Year ReturnCumulative with dividends | +55.6% | +49.9% | +103.8% |
| 5-Year ReturnCumulative with dividends | +44.1% | +46.9% | +139.8% |
| 10-Year ReturnCumulative with dividends | +44.1% | +103.1% | +150.2% |
| CAGR (3Y)Annualised 3-year return | +15.9% | +14.5% | +26.8% |
Risk & Volatility
ECBK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ECBK is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than NBTB's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECBK currently trades 99.1% from its 52-week high vs NBTB's 95.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 0.73x | 0.50x |
| 52-Week HighHighest price in past year | $20.50 | $48.81 | $31.40 |
| 52-Week LowLowest price in past year | $14.82 | $39.20 | $16.27 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +95.6% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 59.4 | 51.0 | 76.8 |
| Avg Volume (50D)Average daily shares traded | 11K | 277K | 323K |
Analyst Outlook
NBTB leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NBTB as "Hold", CARE as "Hold". Consensus price targets imply -1.5% upside for NBTB (target: $46) vs -7.9% for CARE (target: $29). NBTB is the only dividend payer here at 3.06% yield — a key consideration for income-focused portfolios.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold |
| Price TargetConsensus 12-month target | — | $46.00 | $28.50 |
| # AnalystsCovering analysts | — | 10 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% | — |
| Dividend StreakConsecutive years of raises | — | 13 | 0 |
| Dividend / ShareAnnual DPS | — | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.6% | +0.4% | +2.9% |
NBTB leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CARE leads in 1 (Total Returns). 1 tied.
ECBK vs NBTB vs CARE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ECBK or NBTB or CARE a better buy right now?
For growth investors, ECB Bancorp, Inc.
(ECBK) is the stronger pick with 16. 5% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). NBT Bancorp Inc. (NBTB) offers the better valuation at 14. 0x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate NBT Bancorp Inc. (NBTB) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ECBK or NBTB or CARE?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 14. 0x versus Carter Bankshares, Inc. at 22. 1x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ECBK or NBTB or CARE?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +139. 8%, compared to +44. 1% for ECB Bancorp, Inc. (ECBK). Over 10 years, the gap is even starker: CARE returned +150. 2% versus ECBK's +44. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ECBK or NBTB or CARE?
By beta (market sensitivity over 5 years), ECB Bancorp, Inc.
(ECBK) is the lower-risk stock at 0. 45β versus NBT Bancorp Inc. 's 0. 73β — meaning NBTB is approximately 64% more volatile than ECBK relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 166% for ECB Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ECBK or NBTB or CARE?
By revenue growth (latest reported year), ECB Bancorp, Inc.
(ECBK) is pulling ahead at 16. 5% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: ECB Bancorp, Inc. grew EPS 95. 8% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ECBK or NBTB or CARE?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 9. 8% for ECB Bancorp, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 13. 1% for ECBK. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ECBK or NBTB or CARE more undervalued right now?
On forward earnings alone, Carter Bankshares, Inc.
(CARE) trades at 5. 7x forward P/E versus 11. 2x for NBT Bancorp Inc. — 5. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NBTB: -1. 5% to $46. 00.
08Which pays a better dividend — ECBK or NBTB or CARE?
In this comparison, NBTB (3.
1% yield) pays a dividend. ECBK, CARE do not pay a meaningful dividend and should not be held primarily for income.
09Is ECBK or NBTB or CARE better for a retirement portfolio?
For long-horizon retirement investors, NBT Bancorp Inc.
(NBTB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 3. 1% yield, +103. 1% 10Y return). Both have compounded well over 10 years (NBTB: +103. 1%, ECBK: +44. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ECBK and NBTB and CARE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ECBK is a small-cap high-growth stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock. NBTB pays a dividend while ECBK, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.